Sunz Fund
VC Fund
Changsha, China
Sunz Fund is a venture capital firm that focuses on investments in life science, medical health and resources environment sectors.
- Total investments:
- 22
- Last investment:
- Lead investor:
- 41%
Last updated:
For AI agents: llms.txt
Industries Sunz Fund invests in
Stages Sunz Fund invests in
Countries Sunz Fund invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.4M–$7.4M
- Series A
- $1.4M–$14M
- Series B
- $2.8M–$2.8M
Investment Focus
Industry
- Medical 10 (45%)
- Health Care 9 (41%)
- Biotechnology 9 (41%)
- Biopharma 3 (14%)
- Manufacturing 3 (14%)
Stage
- Series A 7 (32%)
- Seed 5 (23%)
- Series B 4 (18%)
- Angel 2 (9%)
- Series C 2 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Wen Zhou
Founder & President
|
Founder & President | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Infineon Multiomics is a biotechnology company that provides research and application of space multiomics technology. | $7.4M / Seed / Mar 24, 2026 | ||
| Casibrain Technology is a medical device enterprise that has grown up from the Institute of Automation. | Series B / Mar 10, 2026 | ||
Zhongnong Provenance
|
Zhongnong Provenance is an agricultural animal design and breeding service provider. | Series A / Nov 03, 2025 | |
| Hunan Nuohexin Biotechnology is a provider and developer of plant-derived recombinant protein expression products with technology research and product development, integrating production, research and development, sales, and services that can produce monoclonal antibodies, cell growth factors, vaccines, and plant-derived diagnostic antibodies. | $1.4M / Angel / Jul 03, 2024 | ||
Zhihe Biotechnology
|
Zhihe Bio is a synthetic biology manufacturer of oleochemicals. | $1.4M / Seed / May 20, 2024 | |
Errui Xinyue
|
Errui Xinyue is a developer of early diagnosis technology and products for neurodegenerative diseases. It focuses on the research and use of exosome-related technologies and is committed to progressing the advancement of life and health through technological innovation. | Seed / Mar 12, 2024 | |
| Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services. | $14.1M / Series A / Dec 14, 2023 | ||
| Barty Medical develops, manufactures, and markets coronary drug balloons, peripheral drug balloons, coronary PTCA balloons, peripheral PTA balloons, peripheral drug stents, supporting catheter sheaths, vascular interventional devices, and implanted devices. | $14.1M / Series C / Dec 14, 2023 | ||
| Meibai bio focuses on the R&D, production & sales of biological scaffold material for maxillofacial tissue regeneration for medical and medical plastic and cosmetic clinical needs. | Series A / Sep 14, 2023 | ||
| Yingsheng Biotechnology Co., Ltd. (referred to as Yingsheng Bio) was established in 2009, and is committed to the application of molecular diagnostic techniques such as maternal and child health, neonatal genetic diseases, metabolic diseases, birth defects and other human genetics, and national eugenics engineering. Yingsheng's product lineincludes 45 innovative genetic metabolic disease screening reagents, 14 vitamins determination reagents, mass spectrometer automatic intelligent processing platform, and ultra-high performance liquid chromatography tandem mass spectrometry detection system. level. | Series C / Mar 29, 2022 | ||
| See all 22 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sunz Fund invest in?
Sunz Fund invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Seed stage. Most of the 22 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Sunz Fund invest in?
Sunz Fund typically joins rounds of $1.4M–$7.4M at Seed, $1.4M–$14M at Series A and $2.8M–$2.8M at Series B. These are whole funding-round sizes, not Sunz Fund's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Sunz Fund took part in.
How do I contact Sunz Fund?
Public channels for Sunz Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Sunz Fund?
The team at Sunz Fund includes Wen Zhou (Founder & President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
